IP Verse

Ferring B.v. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ferring B.v.

Patent Number:
EP3278809
Title:
Safe Desmopressin Administration
Applicant:
ALLERGAN, INC.
Opposition Date:
Aug 20, 2020
Patent Number:
EP2854790
Title:
Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture Media
Applicant:
ARES TRADING SA
Opposition Date:
May 14, 2019
Patent Number:
EP2381923
Title:
Safe Desmopressin Administration
Applicant:
ACERUS PHARMACEUTICALS USA, LLC
Opposition Date:
May 1, 2019
Patent Number:
EP2164877
Title:
The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein Production
Applicant:
MERCK SERONO S.A.
Opposition Date:
Sep 4, 2018
Patent Number:
EP2442821
Title:
Safe Desmopressin Administration
Applicant:
ACERUS PHARMACEUTICALS USA, LLC
Opposition Date:
Mar 12, 2018

Latest patents of Ferring B.v. opposed by its competitors

Patent:
EP3222272
Grant Date:
Nov 3, 2021
Title:
Pharmaceutical Composition
Oppositions:
1
Patent:
EP3144318
Grant Date:
Sep 23, 2020
Title:
Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation
Oppositions:
1
Patent:
EP2292252
Grant Date:
Aug 7, 2019
Title:
Unitary Combination Of Fsh And Hcg
Oppositions:
1
Patent:
EP3045471
Grant Date:
Mar 29, 2017
Title:
Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation
Oppositions:
1

Competitors of Ferring B.v.

ALLERGAN, INC.

MERCK SERONO S.A.

SERENITY PHARMACEUTICALS LLC

Want to track Ferring B.v.?

Feel free to send us a message here and we will get back to you